Advertisement

Ads Placeholder
Loading...

AnaptysBio, Inc.

ANAB•NASDAQ
Healthcare
Biotechnology
$64.98
$2.55(4.08%)
U.S. Market is Open • 15:12

AnaptysBio, Inc. (ANAB) Stock Overview

Explore AnaptysBio, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio-129.98
EPS (TTM)$-0.46
ROE18.14%
Fundamental Analysis

AI Price Forecasts

1 Month$56.78
3 Months$54.27
1 Year Target$38.50

ANAB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AnaptysBio, Inc. (ANAB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.59, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $38.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -129.98 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.48%
5-Day Change
10.57%
1-Month Change
12.13%
3-Month Change
37.43%
6-Month Change
108.001%
Year-to-Date (YTD) Change
38.22%
1-Year Change
249.44%
3-Year Change
189.25%
5-Year Change
192.24%
All-Time (Max) Change
265.47%

Contact Information

https://www.anaptysbio.com
858 362 6295
10770 Wateridge Circle, San Diego, CA, 92121-5801

Company Facts

1,360 Employees
IPO DateJan 26, 2017
CountryUS
Actively Trading

Frequently Asked Questions